Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Neoplasms 3Prostatic Neoplasms 2Fatigue 2Breast Neoplasms 2Xerostomia 1Vomiting 1Uterine Cervical Neoplasms 1Psychological Well-Being 1Parasomnias 1Pancreatic Neoplasms 1Pain 1Oropharyngeal Neoplasms 1Obesity 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Nausea 1Multiple Myeloma 1Mucositis 1Motor Activity 1Mesothelioma 1Malignant Neoplasms of Female Genital Organs 1Lung Neoplasms 1Lung Diseases 1Liver Neoplasms 1Hyperinsulinism 1Head and Neck Neoplasms 1Esophagitis 1Digestive System Diseases 1Colon or Upper Rectum Adenocarcinoma 1Brain Neoplasms 1

Interventions

Pemetrexed 5Nivolumab 4Cisplatin 4Carboplatin 4Ipilimumab 3durvalumab 1atezolizumab 1Vorinostat 1Talc 1Surveys and Questionnaires 1Radiotherapy, Intensity-Modulated 1Radiation 1Platinum 1Injections 1Cerebral Decortication 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Mesothelioma × Surveys and Questionnaires × Clear all
NCT02511600 2015-12-15

Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication

M.D. Anderson Cancer Center

Phase 3 Withdrawn
Other solid neoplasmThoracic

Lung Diseases, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡